news
Researchers propose dumping BMI for visceral fat and metabolic markers
A landmark study challenges the two-century-old Body Mass Index, urging clinicians to track visceral fat and organ stress instead. The proposed criteria combine waist-to-height ratio with biomarkers of insulin resistance and chronic inflammation. The change reclassifies millions of people misdiagnosed by simple height-and-weight math.
A landmark study challenges the two-century-old Body Mass Index, urging clinicians to track visceral fat and organ stress instead. The proposed criteria combine waist-to-height ratio with biomarkers of insulin resistance and chronic inflammation. The change reclassifies millions of people misdiagnosed by simple height-and-weight math.
The architecture take
I spent years letting an arbitrary height-to-weight calculation dictate whether my metabolic health was on track, which was absurd in retrospect. BMI was invented by an astronomer in the 1830s who studied Belgian population averages, not cellular health. The new clinical criteria target what visceral fat actually does to tissue. Fat wrapped around organs releases inflammatory cytokines and disrupts liver insulin clearance, spiking blood sugar and driving baseline cortisol up. Subcutaneous fat doesn't behave that way. I stopped stepping on scales. I track waist-to-height ratio and fasting insulin instead, because muscle mass routinely trips the overweight threshold on traditional charts. Insurers haven't budged from nineteenth-century arithmetic because a scale costs twenty dollars and an accurate scan costs three hundred. Watching clinicians finally replace a lazy calculation with actual hormonal and tissue markers is overdue progress. Routine metabolic screening is finally catching up to basic biology.